| 摘要 |
<p>The invention provides the use of a protein selected from the B-oligomer of pertussis toxin, an individual subunit S2, S3, S4 or S5 thereof, or a combination of said subunits, for the preparation of pharmaceutical compositions comprising them for the treatment of autoimmune diseases.</p> |
